Biotech's Pulse: Gene-Editing's Leap, Cancer's New Fights, and What's Stirring the Industry

The Great Weight Shift: Biotech's Quest for What's Next in Obesity Care

The Shadow Returns: What Trump's Drug Pricing Encore Means for Your Medicine Cabinet

Trump Unleashes Trade Weapon Against Global Partners Over 'Unfair' Drug Prices

Biotech's Vanguard: Novo Nordisk, Omeros, and GSK Charting New Territories in Medical Innovation

AstraZeneca's Landmark Deal: Lowering Drug Prices for Medicaid Under Trump Administration Agreement

Revolutionizing Healthcare: Trump's Bold Stance on Lowering Prescription Drug Costs

President Trump's Landmark Initiative to Tackle Skyrocketing Prescription Drug Costs

Trump's Bold New Blueprint: Unveiling Ambitious Plans to Slash Prescription Drug Costs

Rethinking Drug Costs: Trump's Bold Bid to Reshape Pharmaceutical Pricing

White House Shelves Generic Drug Tariffs, Paving the Way for Indian Pharma's Continued Success

Trump's Pharma Tariffs: A Risky Gamble on American Innovation and Health

The Perilous Bargain: Are We Trading Future Cures for Today's Drug Savings?

Crucial Medicare Drug Price Loophole Fix Stalled: A Setback for Patient Savings

The Enduring Battle: Trump, Pfizer, and the Shifting Tides of Prescription Drug Pricing

TrumpRx Unveils Groundbreaking Platform to Dramatically Cut Prescription Drug Costs

Game Changer: Pfizer Secures Tariff Reprieve, Vows Lower Drug Prices for Millions of Americans

Pfizer's Bold New Chapter: Shares Soar as Pharma Giant Commits to Sweeping US Drug Price Cuts

Trump Hails "Historic" Deal with Pfizer to Drastically Cut Drug Prices

Trump's Bold Move: White House Pressures Pharma Giants for Lower Drug Prices

Trump's Landmark Drug Price Promise: A Deadline Vanished, Unnoticed

Trump's Bold Pharmaceutical Tariff Plan: Unpacking the 'America First' Drug Strategy

Trump's Bold Pharmaceutical Tariff Plan: Unpacking the Potential Impacts on America's Drug Supply

Trump's Tariff Gamble: Experts Unpack the Real Cost of Pharma Duties

US Tariffs Threaten India's Generic Pharma Powerhouse: Himachal Manufacturers Sound Alarm

Trump's Tariff Vision: A Risky Prescription for Soaring Drug Costs and Shaken Supply Chains

Trump's Audacious Pharma Tariff Gamble: Will American Drug Prices Skyrocket?

Trump's Tariff Tempest: Why a 100% Drug Tax Could Sink India's Pharma Giants and Ignite a US Healthcare Crisis

Trump's Looming 100% Pharma Tariff: A Catastrophic Blow for India's Global Pharmacy?

Trump Unleashes 100% Tariff on Imported Branded Drugs, Shaking Up Global Pharma

AstraZeneca Unleashes Legal Barrage Against Medicare Drug Price Controls

The Enduring Saga of Drug Prices: Trump's Lingering Shadow on Healthcare Affordability

Kenvue's Remarkable Rebound: Shaking Off White House Pressure and Soaring Back

Historic Triumph for American Patients: Pharma Giant Levels Drug Prices Across US and Europe Following Trump's Relentless Advocacy

The Unseen Weight: Unpacking the Escalating Costs and Long-Term Dependency of Weight-Loss Jabs

The White House's 'Affordable Drugs' Website: A Digital Band-Aid on a Crushing Problem?

Novartis Plots Strategic Price Adjustments in US as Trump's MFN Deadline Looms

Trump Administration Unveils Sweeping Crackdown on Pharmaceutical Ad Transparency

Unmasking Big Pharma: Trump Administration Mandates Price Transparency in Drug Ads